![Alfred Hansel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alfred Hansel
Directeur Général chez oncgnostics GmbH
Profil
Alfred Hansel is the founder and Chief Executive Officer of oncgnostics GmbH, a company founded in 2012.
He holds a doctorate degree from the University of Freiburg and an undergraduate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Postes actifs de Alfred Hansel
Sociétés | Poste | Début |
---|---|---|
oncgnostics GmbH
![]() oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Directeur Général | 01/02/2012 |
Formation de Alfred Hansel
Friedrich-Alexander University of Erlangen-Nuremberg | Undergraduate Degree |
University of Freiburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
oncgnostics GmbH
![]() oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Health Technology |